These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 32326425)
1. Photobiomodulation for Parkinson's Disease in Animal Models: A Systematic Review. Salehpour F; Hamblin MR Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326425 [TBL] [Abstract][Full Text] [Related]
2. Transcranial photobiomodulation in the management of brain disorders. Montazeri K; Farhadi M; Fekrazad R; Akbarnejad Z; Chaibakhsh S; Mahmoudian S J Photochem Photobiol B; 2021 Aug; 221():112207. PubMed ID: 34119804 [TBL] [Abstract][Full Text] [Related]
3. Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's Disease: A Case Series Conducted During COVID-19. Liebert A; Bicknell B; Laakso EL; Jalilitabaei P; Tilley S; Kiat H; Mitrofanis J Photobiomodul Photomed Laser Surg; 2022 Feb; 40(2):112-122. PubMed ID: 34919459 [No Abstract] [Full Text] [Related]
4. Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease. Oueslati A; Lovisa B; Perrin J; Wagnières G; van den Bergh H; Tardy Y; Lashuel HA PLoS One; 2015; 10(10):e0140880. PubMed ID: 26484876 [TBL] [Abstract][Full Text] [Related]
5. Photobiomodulation Mitigates Cerebrovascular Leakage Induced by the Parkinsonian Neurotoxin MPTP. San Miguel M; Martin KL; Stone J; Johnstone DM Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31590236 [TBL] [Abstract][Full Text] [Related]
6. Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study. Liebert A; Bicknell B; Laakso EL; Heller G; Jalilitabaei P; Tilley S; Mitrofanis J; Kiat H BMC Neurol; 2021 Jul; 21(1):256. PubMed ID: 34215216 [TBL] [Abstract][Full Text] [Related]
7. Parkinson's Disease and Photobiomodulation: Potential for Treatment. Bicknell B; Liebert A; Herkes G J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38276234 [TBL] [Abstract][Full Text] [Related]
8. Transcranial photobiomodulation ameliorates midbrain and striatum neurochemical impairments and behavioral deficits in reserpine-induced parkinsonism in rats. Mohammed HS; Hosny EN; Sawie HG; Khadrawy YA Photochem Photobiol Sci; 2023 Dec; 22(12):2891-2904. PubMed ID: 37917308 [TBL] [Abstract][Full Text] [Related]
9. Pre-conditioning with Remote Photobiomodulation Modulates the Brain Transcriptome and Protects Against MPTP Insult in Mice. Ganeshan V; Skladnev NV; Kim JY; Mitrofanis J; Stone J; Johnstone DM Neuroscience; 2019 Feb; 400():85-97. PubMed ID: 30625333 [TBL] [Abstract][Full Text] [Related]
10. "Buckets": Early Observations on the Use of Red and Infrared Light Helmets in Parkinson's Disease Patients. Hamilton CL; El Khoury H; Hamilton D; Nicklason F; Mitrofanis J Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):615-622. PubMed ID: 31536464 [No Abstract] [Full Text] [Related]
11. Red and NIR light dosimetry in the human deep brain. Pitzschke A; Lovisa B; Seydoux O; Zellweger M; Pfleiderer M; Tardy Y; Wagnières G Phys Med Biol; 2015 Apr; 60(7):2921-37. PubMed ID: 25789711 [TBL] [Abstract][Full Text] [Related]
12. Penetration Profiles of Visible and Near-Infrared Lasers and Light-Emitting Diode Light Through the Head Tissues in Animal and Human Species: A Review of Literature. Salehpour F; Cassano P; Rouhi N; Hamblin MR; De Taboada L; Farajdokht F; Mahmoudi J Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):581-595. PubMed ID: 31553265 [No Abstract] [Full Text] [Related]
13. Mitochondrial Dysfunction and Parkinson's Disease-Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy. Foo ASC; Soong TW; Yeo TT; Lim KL Front Aging Neurosci; 2020; 12():89. PubMed ID: 32308618 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review. Berman MH; Nichols TW Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):623-634. PubMed ID: 31647776 [No Abstract] [Full Text] [Related]
15. Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms. Caldieraro MA; Cassano P J Affect Disord; 2019 Jan; 243():262-273. PubMed ID: 30248638 [TBL] [Abstract][Full Text] [Related]
16. Remote photobiomodulation targeted at the abdomen or legs provides effective neuroprotection against parkinsonian MPTP insult. Gordon LC; Martin KL; Torres N; Benabid AL; Mitrofanis J; Stone J; Moro C; Johnstone DM Eur J Neurosci; 2023 May; 57(9):1611-1624. PubMed ID: 36949610 [TBL] [Abstract][Full Text] [Related]
17. Photobiomodulation for Neurodegenerative Diseases: A Scoping Review. Shen Q; Guo H; Yan Y Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338901 [TBL] [Abstract][Full Text] [Related]
19. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
20. Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson's Disease: A Comparison of Direct and Indirect Systemic Stimulations. Johnstone DM; Hamilton C; Gordon LC; Moro C; Torres N; Nicklason F; Stone J; Benabid AL; Mitrofanis J J Alzheimers Dis; 2021; 83(4):1399-1413. PubMed ID: 33843683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]